Quantcast

Latest Pharmacogenetics Stories

2010-10-26 14:17:00

VISTA, Calif., Oct. 26 /PRNewswire/ -- AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer. "We are very excited to receive...

2010-09-28 07:00:00

RICHMOND, Va. and CINCINNATI, Sept. 28 /PRNewswire/ -- Diamond Healthcare Corporation and AssureRx Health, Inc. today announced that Diamond has initiated the roll-out of AssureRx Health's GeneSightRx pharmacogenetic test in 10 of its nationwide behavioral health units with broader adoption in its 30-state network scheduled through 2011. The initial launch involves physicians' use of the GeneSightRx lab-developed test to support the treatment of patients with psychiatric disorders. From...

2010-09-15 06:50:00

WASHINGTON and LONDON, September 15, 2010 /PRNewswire/ -- Diaceutics Limited (http://www.diaceutics.com) and London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, today announce a strategic partnership to develop software decision tools that will provide biopharmaceutical companies with rapid and extensive access to the world's leading academic biomarker research groups. The new tools will enable commercial biomarker research teams...

2010-08-10 07:00:00

CINCINNATI, Aug. 10 /PRNewswire/ -- AssureRx Health, Inc. today announced that it has received accreditation from the College of American Pathologists (CAP) for the delivery of high-quality, reliable laboratory pharmacogenetic testing services that meet or exceed regulatory laboratory standards and ensure commitment to patient care. The goal of the CAP Laboratory Accreditation Program is to improve patient safety by advancing the quality of pathology and laboratory services through...

2010-07-22 07:25:00

LONDON, July 22, 2010 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that it has augmented the strength of its team with the appointment of two senior advisers, Professors Stephen DeCherney and Munir Pirmohamed. With their extensive clinical, healthcare, and drug development expertise, their guidance will be invaluable to London Genetics. Stephen DeCherney MD, MPH, is Professor of...

2010-06-24 09:20:00

LOUISVILLE, Ky., June 24/PRNewswire/ -- PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. (GH). The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine." "The affiliation with Generation Health takes our company, and the reality...

2010-05-12 07:05:00

LONDON, May 12, 2010 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that the importance of this approach is being highlighted with the publication of its inaugural conference [1] proceedings in the May 2010 issue of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To Improve Clinical Development and Patient Care'[2], brought together pharma and biotech companies,...

2010-03-23 07:00:00

CINCINNATI, March 23 /PRNewswire/ -- AssureRx Health, Inc., a personalized medicine company specializing in pharmacogenetic products to help physicians select the right drug and right dose for psychiatric patients, announced that Donald R. Wright, Jr. has been promoted to Senior Vice President, Operations and Technology. His expanded responsibilities include managing the Company's web-based software product development, overseeing information technology and molecular genetics laboratory...

2010-03-08 07:00:00

CINCINNATI, March 8 /PRNewswire/ -- AssureRx Health, Inc., a personalized medicine company focused on pharmacogenetics to aid in the treatment of patients with psychiatric disorders, today announced that it has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenetic test. GeneSightRx® measures and analyzes more than forty clinically important genetic variants that affect patients' response to medications prescribed in psychiatric medicine. The CYP1A2 gene...

2010-02-24 06:57:00

LONDON, February 24, 2010 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, has awarded the first three grants from its proof-of-concept (POC) fund. The awards, to teams at Imperial College London and University College London, are for research in the areas of immunotherapy, schizophrenia and heart disease. Financial details were not disclosed. The purpose of projects funded by the POC fund is to illustrate...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related